Document is current
Any future updates will be listed below
-
Authors
Neri, Paola
Leblay, Noémie https://orcid.org/0000-0002-4202-7127
Lee, Holly
Gulla, Annamaria
Bahlis, Nizar J. https://orcid.org/0000-0001-7353-7034
Anderson, Kenneth C. https://orcid.org/0000-0002-6418-0886
- License Information
-
More Information
Article History
Accepted: 5 June 2024
First Online: 3 July 2024
Competing interests
: P.N. reports honoraria from Bristol Myers Squibb (BMS), Janssen, Pfizer and Sanofi, and is a consultant/advisory board member for BMS and Janssen. N.J.B. reports honoraria from Amgen, BMS, Janssen, Pfizer and Sanofi, and is a consultant/advisory board member for BMS, Janssen and Pfizer. K.C.A. is a consultant/advisory board member for Amgen, Astrazeneca, Janssen and Pfizer, and is a board member of 4 Therapeutics, Dynamic Cell Therapies, Next RNA, Starton Therapeutics and Window Therapeutics. N.L., H.L. and A.G. declare no competing interests.
